Pharmaceuticals News and Research

RSS

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Building upon their earlier research on the biology of fat metabolism, Joslin scientists discovered that microRNAs -small RNA molecules that play important roles in regulation in many types of tissue - play a major role in the distribution and determination of fat cells and whole body metabolism.

3 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

Biotest Pharmaceuticals opens new plasma collection center in Valdosta, Georgia

Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at 311 North Patterson Road, in Valdosta, Georgia.

2 Jul 2014

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

2 Jul 2014

Genentech agrees to acquire Seragon Pharmaceuticals

Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.

2 Jul 2014

Telerx acquires C3i to expand business services outside the United States

Telerx, a leader in U.S. customer care services, today announced that it has completed its acquisition of C3i, a leading provider of technology support services for the life sciences industry. This acquisition will provide Telerx with the global infrastructure to expand its business services outside the United States while maintaining its current domestic operations. The acquisition was completed on June 30, 2014.

1 Jul 2014

NCCN Policy Summit to address impact of health care reform on academic oncology practice

On July 10, 2014, the National Comprehensive Cancer Network® (NCCN®) will host the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice, at The Westin Arlington Gateway in Arlington, Virginia, as part of the NCCN Oncology Policy Program.

1 Jul 2014

Inaccurate doctor lists hurt access for low-income Californians

Meanwhile, confusion over limited providers also has led to unforeseen bills for enrollees in private plans in California, reports The Los Angeles Times. Other stories look at the growing number of insurers who want to participate in the online marketplaces and how 19 states have passed laws restricting the workers who help consumers sign up, despite a new federal rule eliminating many such restrictions.

1 Jul 2014

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Medican Enterprises, Inc. a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd ("IHMML").

30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Complete analysis of regenerative medicine market

According to a new market research report by Allied Market Research titled, "GlobalRegenerative MedicineMarket (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020).

30 Jun 2014

Quantum Materials secures anti-counterfeiting quantum dot detection technology

Quantum Materials Corporation (OTCQB:QTMM) announces securing 3D printing and additive manufacturing anti-counterfeiting quantum dot detection technology developed at the Institute for Critical Technology and Applied Science and the Design, Research, and Education for Additive Manufacturing Systems (DREAMS) Laboratory at Virginia Tech.

30 Jun 2014

IXICO and VirtualScopics jointly lease office space in New Hope, Pennsylvania

VirtualScopics, Inc., a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, announced today they are jointly leasing 2,190 sq. ft. of office space in New Hope, Pennsylvania, strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania.

30 Jun 2014

Study identifies effective market research approaches to understand payer needs, decision-making

The Affordable Care Act has been the catalyst for dramatic change in US healthcare. The power structures that influence this $2.8 trillion economic sector are shifting, but one thing is crystal clear: A large percentage of the pharmaceutical sector's top-line revenues flow from payers.

28 Jun 2014

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.

28 Jun 2014

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.

28 Jun 2014

Karolinska Institute Professor calls for innovative solutions for global healthcare

Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.

28 Jun 2014

Members of JUGGLE network collaborate to improve project coordination

The field of life sciences is at the crossroads of biology and medicine and is a key component of the research portfolio of Johannes Gutenberg University Mainz (JGU).

28 Jun 2014

Xenex testifies before U.S. House of Representatives on effectiveness of UV disinfection system in reducing HAI rates

Xenex Disinfection Services, the world leader in UV room disinfection systems, testified yesterday before the U.S. House of Representatives Committee on Science, Space, and Technology; Subcommittee on Research and Technology; and Subcommittee on Oversight.

28 Jun 2014

Pharmaceuticals News and Research

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Biotest Pharmaceuticals opens new plasma collection center in Valdosta, Georgia

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Genentech agrees to acquire Seragon Pharmaceuticals

Telerx acquires C3i to expand business services outside the United States

NCCN Policy Summit to address impact of health care reform on academic oncology practice

Inaccurate doctor lists hurt access for low-income Californians

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Complete analysis of regenerative medicine market

Quantum Materials secures anti-counterfeiting quantum dot detection technology

IXICO and VirtualScopics jointly lease office space in New Hope, Pennsylvania

Study identifies effective market research approaches to understand payer needs, decision-making

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

Karolinska Institute Professor calls for innovative solutions for global healthcare

Members of JUGGLE network collaborate to improve project coordination

Xenex testifies before U.S. House of Representatives on effectiveness of UV disinfection system in reducing HAI rates

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence